Statogen Consulting, North Carolina, was founded by Dr. Stephan Ogenstad in 2006. Dr. Stephan Ogenstad is President of Statogen Consulting LLC since 2006, Founder and Affiliate of Innovalyst LLC, Wake Forest, North Carolina, and In Silico Biosciences, Inc., Massachusetts. Dr. Ogenstad served as statistical advisor and reviewer to members of the Nobel Prize committee of Medicine and Physiology, and was prior to 2006, Vice President of Biometrics at Vertex Pharmaceuticals in Cambridge, Massachusetts, USA. He has 25 years of experience with major pharmaceutical companies and distinguished university hospitals from around the world. Dr. Ogenstad earned a PhD in Statistics from the University of Stockholm, Sweden, and worked as a professor of statistics at the Dept. of Statistics, University of Stockholm. He is an Adjunct Faculty Member and Professor of Biostatistics, Jiann-Ping Hsu College of Public Health, Georgia Southern University, and a member of the International Advisory Committee of the University of North Carolina at Greensboro, USA, and is President of the North Carolina Chapter of the American Statistical Association, Program Chair for the Section on Statistical Consulting for the American Statistical Association, and Course Director of Biostatistics at Center for Professional Advancement, East Brunswick, NJ.

Dr. Ogenstad lectured and taught courses in experimental design, drug development and in various other areas of biostatistics at the Karolinska Institute and the Swedish Academy of Pharmaceutical Sciences in Stockholm, Sweden. He served as senior statistical advisor to members of the Nobel Prize Committee of Medicine and Physiology. He is also a frequent pre�senter at international confer�ences.

Dr. Ogenstad has had numerous professional affiliations as well as society memberships. He has been the president of the Swedish Society for Medical Statistics, council member of the Swedish Statistical Association, council member and cofounder of the European Federation of Statisticians in the Pharmaceutical Industry, and chair of the Massachusetts Biotechnology Council, Biostatistics and Data Management.

During the last 20 years, he has held senior managerial positions in nonclinical and clinical biostatistics and clinical data management with AstraZeneca, Parexel International Corporation, Amgen, and Vertex Pharmaceuticals.

Dr. Ogenstad has contributed to the filing of 18 NDA/BLA submissions in Europe, USA and Japan. He has more than 80 publications, book chapters, and presentations in the areas of biostatistics and medicine.
 
© 2006-2012 - Statogen Consulting, All Rights Reserved     Site Map